Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Franks

Showing results (31-40 of 93) with videos related to

Pageof 10
Sort By:
European Journal of Cancer & Clinical Oncology|January 1, 1987
TNO6 in non small cell lung cancerR J Osborne, M L Slevin, P F Wrigley, et al.
Renal Failure|January 1, 1993
Lithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in manS D Heys, O Eremin, C R Franks, et al.
Clinical Chemistry|December 1, 1980
Creatine kinase isoenzyme patterns in neoplasms of peripheral nerveJ Balaton, G N Hoag, C R Franks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alphaJ Atzpodien, A Körfer, P A Palmer, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer GroupM Adams, I J Kerby, I Rocker, et al.
British Journal of Cancer|May 1, 1977
Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived miceC R Franks, D Bishop, F R Balkwill, et al.
Lancet (London, England)|July 2, 1988
Myocardial injury after interleukin-2 therapyS Osanto, F H Cluitmans, C R Franks, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary resultsN Thatcher, P Taylor, K B Carroll, et al.
Lancet (London, England)|March 25, 1989
Myocardial injury after interleukin-2 therapyF Laghi Pasini, T Di Perri, K van der Plas, et al.
British Journal of Cancer|December 1, 1993
A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancerT J Hamblin, S Sadullah, P Williamson, et al.
Pageof 10

Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
European Journal of Cancer & Clinical Oncology|January 1, 1987
TNO6 in non small cell lung cancerR J Osborne, M L Slevin, P F Wrigley, et al.
Renal Failure|January 1, 1993
Lithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in manS D Heys, O Eremin, C R Franks, et al.
Clinical Chemistry|December 1, 1980
Creatine kinase isoenzyme patterns in neoplasms of peripheral nerveJ Balaton, G N Hoag, C R Franks, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1990
Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alphaJ Atzpodien, A Körfer, P A Palmer, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1989
A comparison of the toxicity and efficacy of cisplatin and carboplatin in advanced ovarian cancer. The Swons Gynaecological Cancer GroupM Adams, I J Kerby, I Rocker, et al.
British Journal of Cancer|May 1, 1977
Growth of acute myeloid leukaemia as discrete subcutaneous tumours in immune-deprived miceC R Franks, D Bishop, F R Balkwill, et al.
Lancet (London, England)|July 2, 1988
Myocardial injury after interleukin-2 therapyS Osanto, F H Cluitmans, C R Franks, et al.
Cancer Treatment Reviews|June 1, 1989
Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary resultsN Thatcher, P Taylor, K B Carroll, et al.
Lancet (London, England)|March 25, 1989
Myocardial injury after interleukin-2 therapyF Laghi Pasini, T Di Perri, K van der Plas, et al.
British Journal of Cancer|December 1, 1993
A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancerT J Hamblin, S Sadullah, P Williamson, et al.
Pageof 10